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Abstract
Hepatoid adenocarcinoma is a rare variant of extrahepatic adenocarcinoma which behaves like hepatocellular
carcinoma in morphology and functionality.
We present a rare case of hepatoid adenocarcinoma of the gallbladder which invades deeply the liver bed, in a 59-
year-old woman. Histologically, most of the mass in the gallbladder was composed of cells with eosinophilic
cytoplasm arranged in a trabecular pattern, which resembled hepatocellular carcinoma. The main differential
diagnosis was hepatocellular carcinoma with invasion into the gallbladder. The gallbladder origin of the hepatoid
adenocarcinoma was verified by the presence of foci of conventional adenocarcinoma, the recognition of high-
grade dysplasia in the adjacent epithelium and the absence of cirrhosis.
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Background
Hepatoid adenocarcinoma (HAC) is a variety of adeno-
carcinoma associated with hepatic differentiation. The
most frequent site of this carcinoma is the stomach.
Only a few cases of HAC of the gallbladder have been
reported [1].
We present a rare case of HAC of the gallbladder
which, to the best of our knowledge, represents the
eighth reported case in the English literature.
Case report
A 59-year-old woman presented with abdominal pain
and complains about general fatigue.
Ultrasonography and computed tomography revealed
a solid mass within the gallbladder, which infiltrates the
adjacent liver without signs of cirrhosis (Figure 1a, b).
Laboratory data was within normal limits. The levels of
serum AFP were not assessed preoperatively. Serological
tests for hepatitis B virus surface antigen and hepatitis C
virus antibody were negative.
Cholecystectomy with resection of the involved liver
subsegments, and regional lymph node dissection were
performed.
Gross examination revealed a white and yellow solid
tumor, measuring 11 × 5 cm, occupying the body of the
gallbladder and invading the liver bed.
Microscopically, the tumor was composed mainly of
“hepatoid cells”, which were characterized by eosinophi-
lic cytoplasm, enlarged nuclei, prominent nucleoi, and
arranged in nests or proliferated in a trabecular and
solid pattern. A few sporadic foci of adenocarcinoma
were mixed with the hepatoid component. Bile plugs
were recognized intracellularly and foci of high-grade
dysplasia were observed in the gallbladder epithelium
adjacent to the tumor (Figure 2). The tumor invaded
deeply the liver bed. None of the lymph nodes dissected
at surgery showed metastasis by the tumor cells.
Immunohistochemically, the carcinoma with hepatoid
features was diffusely stained for a fetoprotein (AFP),
HepPar-1 (Figure 3a) and Hepatocyte-cell antibodies,
but not for Keratin7, whereas the well-differentiated
adenocarcinoma was immunoreactive for Keratin7 but
not for AFP or Hepatocyte-cell. CD10 positivity indi-
cated canalicular differentiation (Figure 3b).
On the basis of histologic and immunohistochemical
findings, the diagnosis of HAC of the gallbladder was
reported. Three months postoperatively, the patient is
still alive without any further therapeutic intervention.
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Hepatoid adenocarcinoma (HAC) is a rare variety of
extrahepatic adenocarcinoma, consisting of foci of both
adenomatous and hepatocellular differentiations which
behave like hepatocellular carcinoma (HCC) in mor-
phology and functionality [1].
HAC was proposed as a specific type of primary gas-
tric cancer by Ishikura et al. in 1985 [2].
Since then, carcinomas with hepatoid differentiation
have been described in a variety of anatomic locations
including the lung, kidney, female reproductive tract,
pancreas, and gallbladder, the stomach being the most
prevalent site [2].
Typically, an elevated level of serum alpha-fetoprotein
(AFP) is detected, although normal levels have also been
reported [1] and clear cell carcinomas of the gallbladder
with or without hepatoid differentiation are often asso-
ciated with high serum levels of AFP [3]. At imaging the
tumor may mimic HCC [1].
As mentioned above, HAC was named because of its
characteristic histopathological features, suggesting
hepatoid differentiation resembling HCC. Generally, the
tumor is composed mainly of large or polygonal cells
with abundant eosinophilic cytoplasm, and it proliferates
in a solid or trabecular pattern, although it sometimes
shows medullary proliferation [4].
Furthermore, some parts which show papillary or tub-
ular structures are often observed in the lamina propriae
and/or submucosal areas [4]. The recognition of bile
production proves the hepatoid nature of cells [2].
Immunohistochemically, many liver specific proteins,
including AFP, albumin, transferin, PIVKA (protein
induced in the absence of vitamin K), and alpha-1-anti-
trypsin, have been detected in the tumor cell cytoplasm.
Of them, AFP is generally considered important for the
diagnosis. However, it is very important to note that
AFP positivity is not necessarily diagnostic of HAC,
because not all HAC are associated with AFP overpro-
duction. Therefore, the diagnosis of HAC should be
made essentially by the histological features of the
tumor [1].
In addition, focal positivity with Keratin7 suggested
the presence of an adenocarcinoma. CD10 positivity
indicated canalicular differentiation and thus hepatocel-
lular origin [5].
The main differential diagnosis is HCC with invasion
into the gallbladder. When HAC of the gallbladder
invades the liver deeply (as in our case), differential
diagnosis of these two tumours can be very difficult [6].
     
Figure 1 Abdominal computed tomography revealed a solid
mass within the gallbladder. 1a and 1b: Abdominal computed
tomography revealed a solid mass within the gallbladder, and
absence of liver nodules.
Figure 2 Tumor cells are arranged in a trabecular and solid
pattern. 2a: Tumor cells are arranged in a trabecular and solid
pattern and containing bile plugs (HE×100), 2b: Tumor cells have
abundant eosinophilic cytoplasm, enlarged nuclei and prominent
nucleoli (HE×400). 2c: Foci of well-differentiated gallbladder
adenocarcinoma (HE×400.), 2d: Foci of high-grade dysplasia were
observed in the gallbladder epithelium adjacent to the tumor
(HE×200)
Figure 3 Intracytoplasmic expression of HepPar-1. 3a:
Intracytoplasmic expression of HepPar-1. 3b: Canalicular staining
pattern for CD10.
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patients is important because HCC arising in non-fibro-
tic liver and without risk factors, such as hepatitis virus
infection, is generally rare, as is lymph node metastasis
at surgery. If the intramucosal foci of adenocarcinoma
are detected histologically in a surgical specimen, the
gallbladder origin is confirmed [6]. In our case, the gall-
bladder origin of the HAC was verified by the presence
of foci of conventional adenocarcinoma but also by the
recognition of high-grade dysplasia in the adjacent
epithelium and the absence of cirrhosis.
Conclusion
We present a rare case of hepatoid adenocarcinoma of
the gallbladder which invades deeply the liver bed, in a
59-year-old woman. The main differential diagnosis was
hepatocellular carcinoma with invasion into the gallblad-
der. The gallbladder origin of the hepatoid adenocarci-
noma was verified by the presence of foci of
conventional adenocarcinoma, the recognition of high-
grade dysplasia in the adjacent epithelium and the
absence of cirrhosis.
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